Although bonded to different target epitopes at the PD-1 molecule,35–38 they had the same mechanism of action (inhibiting the PD-1/PD-L1 immune checkpoint, leading to restoration of T-cell functions against cancer cells), and thus would not significantly affect the interpretation of the study results. This evidence concerns the gene CD274 and cancer.